CRISPR-Cas editing technologies for viral-mediated gene therapies of human diseases: Mechanisms, progress, and challenges

Gene therapy graphical abstract
Boris Kantor, Ph.D., Leanne Duke, Ph.D., Pradeep G. Bhide, Ph.D. (College of Medicine) co-authored “CRISPR-Cas editing technologies for viral-mediated gene therapies of human diseases: Mechanisms, progress, and challenges” published in Molecular Therapy Nucleic Acids.

Learn More